APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Nutrition Solutions

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Parenteral Nutrition Solutions Market Analysis and Forecast 2026-2032

Report ID 174022360220 December 2025201 pages

Choose your research edition.

Industry ResearchParenteral Nutrition Solutions Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Nutrition Solutions Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Parenteral Nutrition Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Nutrition Solutions Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Nutrition Solutions Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Parenteral Nutrition Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Parenteral Nutrition Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Parenteral Nutrition Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Parenteral Nutrition Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Parenteral Nutrition Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Parenteral Nutrition Solutions include Teva Pharmaceutical Industries, Pfizer (Hospira), Fresenius, B. Braun, Baxter International Inc., PSI Ltd, Pisa, Patheon and Ozon Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Parenteral Nutrition Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Parenteral Nutrition Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Parenteral Nutrition Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parenteral Nutrition Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Parenteral Nutrition Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Parenteral Nutrition Solutions revenue, projected growth trends, production technology, application and end-user industry.

Parenteral Nutrition Solutions Segment by Company

Teva Pharmaceutical Industries

Pfizer (Hospira)

Fresenius

B. Braun

Baxter International Inc.

PSI Ltd

Pisa

Patheon

Ozon Pharmaceuticals

Ostuka Pharmaceutical

Kelun Pharma

Huaren

CR Double-Crane

Cook Pharmica

BML Parenteral Drugs

Beximco Pharma

BAG Healthcare

Aspen Holdings

Albert David

Parenteral Nutrition Solutions Segment by Type

Large Volume Parenteral (LVP)

Small Volume Parenteral (SVP)

Parenteral Nutrition Solutions Segment by Application

Basic Infusion

Nutritious Infusion

Therapeutic Infusion

Parenteral Nutrition Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Parenteral Nutrition Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Parenteral Nutrition Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parenteral Nutrition Solutions revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Parenteral Nutrition Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Large Volume Parenteral (LVP) Major Player Table 3. Small Volume Parenteral (SVP) Major Player Table 4. Global Parenteral Nutrition Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Basic Infusion Major Player Table 6. Nutritious Infusion Major Player Table 7. Therapeutic Infusion Major Player Table 8. Parenteral Nutrition Solutions Industry Trends Table 9. Parenteral Nutrition Solutions Industry Drivers Table 10. Parenteral Nutrition Solutions Industry Opportunities and Challenges Table 11. Parenteral Nutrition Solutions Industry Restraints Table 12. Global Parenteral Nutrition Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Parenteral Nutrition Solutions Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Parenteral Nutrition Solutions Market Share by Region (2021-2026) Table 15. Global Parenteral Nutrition Solutions Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Parenteral Nutrition Solutions Market Share by Region (2027-2032) Table 17. Global Parenteral Nutrition Solutions Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Parenteral Nutrition Solutions Revenue Market Share by Players (2021-2026) Table 19. Global Parenteral Nutrition Solutions Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Parenteral Nutrition Solutions Key Players Headquarters & Area Served Table 21. Global Parenteral Nutrition Solutions Players, Product Type & Application Table 22. Global Parenteral Nutrition Solutions Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Parenteral Nutrition Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Parenteral Nutrition Solutions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Parenteral Nutrition Solutions Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Parenteral Nutrition Solutions Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Parenteral Nutrition Solutions Revenue Market Share by Type (2021-2026) Table 29. Global Parenteral Nutrition Solutions Revenue Market Share by Type (2027-2032) Table 30. Global Parenteral Nutrition Solutions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Parenteral Nutrition Solutions Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Parenteral Nutrition Solutions Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Parenteral Nutrition Solutions Revenue Market Share by Application (2021-2026) Table 34. Global Parenteral Nutrition Solutions Revenue Market Share by Application (2027-2032) Table 35. Teva Pharmaceutical Industries Company Information Table 36. Teva Pharmaceutical Industries Business Overview Table 37. Teva Pharmaceutical Industries Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Teva Pharmaceutical Industries Parenteral Nutrition Solutions Product Portfolio Table 39. Teva Pharmaceutical Industries Recent Development Table 40. Pfizer (Hospira) Company Information Table 41. Pfizer (Hospira) Business Overview Table 42. Pfizer (Hospira) Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer (Hospira) Parenteral Nutrition Solutions Product Portfolio Table 44. Pfizer (Hospira) Recent Development Table 45. Fresenius Company Information Table 46. Fresenius Business Overview Table 47. Fresenius Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Fresenius Parenteral Nutrition Solutions Product Portfolio Table 49. Fresenius Recent Development Table 50. B. Braun Company Information Table 51. B. Braun Business Overview Table 52. B. Braun Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. B. Braun Parenteral Nutrition Solutions Product Portfolio Table 54. B. Braun Recent Development Table 55. Baxter International Inc. Company Information Table 56. Baxter International Inc. Business Overview Table 57. Baxter International Inc. Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Baxter International Inc. Parenteral Nutrition Solutions Product Portfolio Table 59. Baxter International Inc. Recent Development Table 60. PSI Ltd Company Information Table 61. PSI Ltd Business Overview Table 62. PSI Ltd Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. PSI Ltd Parenteral Nutrition Solutions Product Portfolio Table 64. PSI Ltd Recent Development Table 65. Pisa Company Information Table 66. Pisa Business Overview Table 67. Pisa Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pisa Parenteral Nutrition Solutions Product Portfolio Table 69. Pisa Recent Development Table 70. Patheon Company Information Table 71. Patheon Business Overview Table 72. Patheon Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Patheon Parenteral Nutrition Solutions Product Portfolio Table 74. Patheon Recent Development Table 75. Ozon Pharmaceuticals Company Information Table 76. Ozon Pharmaceuticals Business Overview Table 77. Ozon Pharmaceuticals Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Ozon Pharmaceuticals Parenteral Nutrition Solutions Product Portfolio Table 79. Ozon Pharmaceuticals Recent Development Table 80. Ostuka Pharmaceutical Company Information Table 81. Ostuka Pharmaceutical Business Overview Table 82. Ostuka Pharmaceutical Parenteral Nutrition Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Ostuka Pharmaceutical Parenteral Nutrition Solutions Product Portfolio Table 84. Ostuka Pharmaceutical Recent Development Table 85. Kelun Pharma Company Information Table 86. Kelun Pharma Business Overview Table 87. Kelun Pharma Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Kelun Pharma Parenteral Nutrition Solutions Product Portfolio Table 89. Kelun Pharma Recent Development Table 90. Huaren Company Information Table 91. Huaren Business Overview Table 92. Huaren Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Huaren Parenteral Nutrition Solutions Product Portfolio Table 94. Huaren Recent Development Table 95. CR Double-Crane Company Information Table 96. CR Double-Crane Business Overview Table 97. CR Double-Crane Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. CR Double-Crane Parenteral Nutrition Solutions Product Portfolio Table 99. CR Double-Crane Recent Development Table 100. Cook Pharmica Company Information Table 101. Cook Pharmica Business Overview Table 102. Cook Pharmica Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Cook Pharmica Parenteral Nutrition Solutions Product Portfolio Table 104. Cook Pharmica Recent Development Table 105. BML Parenteral Drugs Company Information Table 106. BML Parenteral Drugs Business Overview Table 107. BML Parenteral Drugs Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. BML Parenteral Drugs Parenteral Nutrition Solutions Product Portfolio Table 109. BML Parenteral Drugs Recent Development Table 110. Beximco Pharma Company Information Table 111. Beximco Pharma Business Overview Table 112. Beximco Pharma Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Beximco Pharma Parenteral Nutrition Solutions Product Portfolio Table 114. Beximco Pharma Recent Development Table 115. BAG Healthcare Company Information Table 116. BAG Healthcare Business Overview Table 117. BAG Healthcare Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. BAG Healthcare Parenteral Nutrition Solutions Product Portfolio Table 119. BAG Healthcare Recent Development Table 120. Aspen Holdings Company Information Table 121. Aspen Holdings Business Overview Table 122. Aspen Holdings Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Aspen Holdings Parenteral Nutrition Solutions Product Portfolio Table 124. Aspen Holdings Recent Development Table 125. Albert David Company Information Table 126. Albert David Business Overview Table 127. Albert David Parenteral Nutrition Solutions Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Albert David Parenteral Nutrition Solutions Product Portfolio Table 129. Albert David Recent Development Table 130. North America Parenteral Nutrition Solutions Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Parenteral Nutrition Solutions Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Parenteral Nutrition Solutions Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Parenteral Nutrition Solutions Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Parenteral Nutrition Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Parenteral Nutrition Solutions Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Parenteral Nutrition Solutions Revenue by Country (US$ Million) & (2027-2032) Table 137. Europe Parenteral Nutrition Solutions Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Parenteral Nutrition Solutions Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Parenteral Nutrition Solutions Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Parenteral Nutrition Solutions Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Parenteral Nutrition Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Parenteral Nutrition Solutions Revenue by Country (2021-2026) & (US$ Million) Table 143. Europe Parenteral Nutrition Solutions Revenue by Country (US$ Million) & (2027-2032) Table 144. China Parenteral Nutrition Solutions Revenue by Type (2021-2026) & (US$ Million) Table 145. China Parenteral Nutrition Solutions Revenue by Type (2027-2032) & (US$ Million) Table 146. China Parenteral Nutrition Solutions Revenue by Application (2021-2026) & (US$ Million) Table 147. China Parenteral Nutrition Solutions Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Parenteral Nutrition Solutions Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Parenteral Nutrition Solutions Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Parenteral Nutrition Solutions Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Parenteral Nutrition Solutions Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Parenteral Nutrition Solutions Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Parenteral Nutrition Solutions Revenue by Region (US$ Million) & (2021-2026) Table 154. Asia Parenteral Nutrition Solutions Revenue by Region (US$ Million) & (2027-2032) Table 155. SAMEA Parenteral Nutrition Solutions Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Parenteral Nutrition Solutions Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Parenteral Nutrition Solutions Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Parenteral Nutrition Solutions Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Parenteral Nutrition Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Parenteral Nutrition Solutions Revenue by Country (2021-2026) & (US$ Million) Table 161. SAMEA Parenteral Nutrition Solutions Revenue by Country (US$ Million) & (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Parenteral Nutrition Solutions Image Figure 2. Global Parenteral Nutrition Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Nutrition Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 4. Large Volume Parenteral (LVP) Image Figure 5. Small Volume Parenteral (SVP) Image Figure 6. Global Parenteral Nutrition Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Parenteral Nutrition Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 8. Basic Infusion Image Figure 9. Nutritious Infusion Image Figure 10. Therapeutic Infusion Image Figure 11. Global Parenteral Nutrition Solutions Market Size (US$ Million) & (2021-2032) Figure 12. Global Parenteral Nutrition Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Parenteral Nutrition Solutions Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Parenteral Nutrition Solutions Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Parenteral Nutrition Solutions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Parenteral Nutrition Solutions Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Parenteral Nutrition Solutions Revenue Market Share by Type (2021-2032) Figure 19. Global Parenteral Nutrition Solutions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Parenteral Nutrition Solutions Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Parenteral Nutrition Solutions Revenue Market Share by Application (2021-2032) Figure 22. North America Parenteral Nutrition Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Parenteral Nutrition Solutions Revenue Share by Type (2021-2032) Figure 24. North America Parenteral Nutrition Solutions Revenue Share by Application (2021-2032) Figure 25. North America Parenteral Nutrition Solutions Revenue Share by Country (2021-2032) Figure 26. United States Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Parenteral Nutrition Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Parenteral Nutrition Solutions Revenue Share by Type (2021-2032) Figure 31. Europe Parenteral Nutrition Solutions Revenue Share by Application (2021-2032) Figure 32. Europe Parenteral Nutrition Solutions Revenue Share by Country (2021-2032) Figure 33. Germany Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Parenteral Nutrition Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Parenteral Nutrition Solutions Revenue Share by Type (2021-2032) Figure 43. China Parenteral Nutrition Solutions Revenue Share by Application (2021-2032) Figure 44. Asia Parenteral Nutrition Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Parenteral Nutrition Solutions Revenue Share by Type (2021-2032) Figure 46. Asia Parenteral Nutrition Solutions Revenue Share by Application (2021-2032) Figure 47. Asia Parenteral Nutrition Solutions Revenue Share by Region (2021-2032) Figure 48. Japan Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Parenteral Nutrition Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Parenteral Nutrition Solutions Revenue Share by Type (2021-2032) Figure 56. SAMEA Parenteral Nutrition Solutions Revenue Share by Application (2021-2032) Figure 57. SAMEA Parenteral Nutrition Solutions Revenue Share by Country (2021-2032) Figure 58. Brazil Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Parenteral Nutrition Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Large Volume Parenteral (LVP)
  • Small Volume Parenteral (SVP)
Applications
  • Basic Infusion
  • Nutritious Infusion
  • Therapeutic Infusion
Companies covered
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Fresenius
  • B. Braun
  • Baxter International Inc.
  • PSI Ltd
  • Pisa
  • Patheon
  • Ozon Pharmaceuticals
  • Ostuka Pharmaceutical
  • Kelun Pharma
  • Huaren
  • CR Double-Crane
  • Cook Pharmica
  • BML Parenteral Drugs
  • Beximco Pharma
  • BAG Healthcare
  • Aspen Holdings
  • Albert David

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Parenteral Nutrition Solutions Market by Type
  3. 1.2.1 Global Parenteral Nutrition Solutions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Large Volume Parenteral (LVP)
  5. 1.2.3 Small Volume Parenteral (SVP)
  6. 1.3 Parenteral Nutrition Solutions Market by Application
  7. 1.3.1 Global Parenteral Nutrition Solutions Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Basic Infusion
  9. 1.3.3 Nutritious Infusion
  10. 1.3.4 Therapeutic Infusion
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Parenteral Nutrition Solutions Market Dynamics
  1. 2.1 Parenteral Nutrition Solutions Industry Trends
  2. 2.2 Parenteral Nutrition Solutions Industry Drivers
  3. 2.3 Parenteral Nutrition Solutions Industry Opportunities and Challenges
  4. 2.4 Parenteral Nutrition Solutions Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Parenteral Nutrition Solutions Market Perspective (2021-2032)
  2. 3.2 Global Parenteral Nutrition Solutions Growth Trends by Region
  3. 3.2.1 Global Parenteral Nutrition Solutions Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Parenteral Nutrition Solutions Market Size by Region (2021-2026)
  5. 3.2.3 Global Parenteral Nutrition Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Parenteral Nutrition Solutions Revenue by Players
  2. 4.1.1 Global Parenteral Nutrition Solutions Revenue by Players (2021-2026)
  3. 4.1.2 Global Parenteral Nutrition Solutions Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Parenteral Nutrition Solutions Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Parenteral Nutrition Solutions Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Parenteral Nutrition Solutions Key Players Headquarters & Area Served
  7. 4.4 Global Parenteral Nutrition Solutions Players, Product Type & Application
  8. 4.5 Global Parenteral Nutrition Solutions Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Parenteral Nutrition Solutions Market CR5 and HHI
  11. 4.6.3 2025 Parenteral Nutrition Solutions Tier 1, Tier 2, and Tier 3
5 Parenteral Nutrition Solutions Market Size by Type
  1. 5.1 Global Parenteral Nutrition Solutions Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Parenteral Nutrition Solutions Revenue by Type (2021-2032)
  3. 5.3 Global Parenteral Nutrition Solutions Revenue Market Share by Type (2021-2032)
6 Parenteral Nutrition Solutions Market Size by Application
  1. 6.1 Global Parenteral Nutrition Solutions Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Parenteral Nutrition Solutions Revenue by Application (2021-2032)
  3. 6.3 Global Parenteral Nutrition Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries
  2. 7.1.1 Teva Pharmaceutical Industries Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Parenteral Nutrition Solutions Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 7.2 Pfizer (Hospira)
  8. 7.2.1 Pfizer (Hospira) Company Information
  9. 7.2.2 Pfizer (Hospira) Business Overview
  10. 7.2.3 Pfizer (Hospira) Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer (Hospira) Parenteral Nutrition Solutions Product Portfolio
  12. 7.2.5 Pfizer (Hospira) Recent Developments
  13. 7.3 Fresenius
  14. 7.3.1 Fresenius Company Information
  15. 7.3.2 Fresenius Business Overview
  16. 7.3.3 Fresenius Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fresenius Parenteral Nutrition Solutions Product Portfolio
  18. 7.3.5 Fresenius Recent Developments
  19. 7.4 B. Braun
  20. 7.4.1 B. Braun Company Information
  21. 7.4.2 B. Braun Business Overview
  22. 7.4.3 B. Braun Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  23. 7.4.4 B. Braun Parenteral Nutrition Solutions Product Portfolio
  24. 7.4.5 B. Braun Recent Developments
  25. 7.5 Baxter International Inc.
  26. 7.5.1 Baxter International Inc. Company Information
  27. 7.5.2 Baxter International Inc. Business Overview
  28. 7.5.3 Baxter International Inc. Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Baxter International Inc. Parenteral Nutrition Solutions Product Portfolio
  30. 7.5.5 Baxter International Inc. Recent Developments
  31. 7.6 PSI Ltd
  32. 7.6.1 PSI Ltd Company Information
  33. 7.6.2 PSI Ltd Business Overview
  34. 7.6.3 PSI Ltd Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PSI Ltd Parenteral Nutrition Solutions Product Portfolio
  36. 7.6.5 PSI Ltd Recent Developments
  37. 7.7 Pisa
  38. 7.7.1 Pisa Company Information
  39. 7.7.2 Pisa Business Overview
  40. 7.7.3 Pisa Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pisa Parenteral Nutrition Solutions Product Portfolio
  42. 7.7.5 Pisa Recent Developments
  43. 7.8 Patheon
  44. 7.8.1 Patheon Company Information
  45. 7.8.2 Patheon Business Overview
  46. 7.8.3 Patheon Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Patheon Parenteral Nutrition Solutions Product Portfolio
  48. 7.8.5 Patheon Recent Developments
  49. 7.9 Ozon Pharmaceuticals
  50. 7.9.1 Ozon Pharmaceuticals Company Information
  51. 7.9.2 Ozon Pharmaceuticals Business Overview
  52. 7.9.3 Ozon Pharmaceuticals Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Ozon Pharmaceuticals Parenteral Nutrition Solutions Product Portfolio
  54. 7.9.5 Ozon Pharmaceuticals Recent Developments
  55. 7.10 Ostuka Pharmaceutical
  56. 7.10.1 Ostuka Pharmaceutical Company Information
  57. 7.10.2 Ostuka Pharmaceutical Business Overview
  58. 7.10.3 Ostuka Pharmaceutical Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Ostuka Pharmaceutical Parenteral Nutrition Solutions Product Portfolio
  60. 7.10.5 Ostuka Pharmaceutical Recent Developments
  61. 7.11 Kelun Pharma
  62. 7.11.1 Kelun Pharma Company Information
  63. 7.11.2 Kelun Pharma Business Overview
  64. 7.11.3 Kelun Pharma Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Kelun Pharma Parenteral Nutrition Solutions Product Portfolio
  66. 7.11.5 Kelun Pharma Recent Developments
  67. 7.12 Huaren
  68. 7.12.1 Huaren Company Information
  69. 7.12.2 Huaren Business Overview
  70. 7.12.3 Huaren Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Huaren Parenteral Nutrition Solutions Product Portfolio
  72. 7.12.5 Huaren Recent Developments
  73. 7.13 CR Double-Crane
  74. 7.13.1 CR Double-Crane Company Information
  75. 7.13.2 CR Double-Crane Business Overview
  76. 7.13.3 CR Double-Crane Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CR Double-Crane Parenteral Nutrition Solutions Product Portfolio
  78. 7.13.5 CR Double-Crane Recent Developments
  79. 7.14 Cook Pharmica
  80. 7.14.1 Cook Pharmica Company Information
  81. 7.14.2 Cook Pharmica Business Overview
  82. 7.14.3 Cook Pharmica Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cook Pharmica Parenteral Nutrition Solutions Product Portfolio
  84. 7.14.5 Cook Pharmica Recent Developments
  85. 7.15 BML Parenteral Drugs
  86. 7.15.1 BML Parenteral Drugs Company Information
  87. 7.15.2 BML Parenteral Drugs Business Overview
  88. 7.15.3 BML Parenteral Drugs Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BML Parenteral Drugs Parenteral Nutrition Solutions Product Portfolio
  90. 7.15.5 BML Parenteral Drugs Recent Developments
  91. 7.16 Beximco Pharma
  92. 7.16.1 Beximco Pharma Company Information
  93. 7.16.2 Beximco Pharma Business Overview
  94. 7.16.3 Beximco Pharma Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Beximco Pharma Parenteral Nutrition Solutions Product Portfolio
  96. 7.16.5 Beximco Pharma Recent Developments
  97. 7.17 BAG Healthcare
  98. 7.17.1 BAG Healthcare Company Information
  99. 7.17.2 BAG Healthcare Business Overview
  100. 7.17.3 BAG Healthcare Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  101. 7.17.4 BAG Healthcare Parenteral Nutrition Solutions Product Portfolio
  102. 7.17.5 BAG Healthcare Recent Developments
  103. 7.18 Aspen Holdings
  104. 7.18.1 Aspen Holdings Company Information
  105. 7.18.2 Aspen Holdings Business Overview
  106. 7.18.3 Aspen Holdings Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Aspen Holdings Parenteral Nutrition Solutions Product Portfolio
  108. 7.18.5 Aspen Holdings Recent Developments
  109. 7.19 Albert David
  110. 7.19.1 Albert David Company Information
  111. 7.19.2 Albert David Business Overview
  112. 7.19.3 Albert David Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Albert David Parenteral Nutrition Solutions Product Portfolio
  114. 7.19.5 Albert David Recent Developments
8 North America
  1. 8.1 North America Parenteral Nutrition Solutions Revenue (2021-2032)
  2. 8.2 North America Parenteral Nutrition Solutions Revenue by Type (2021-2032)
  3. 8.2.1 North America Parenteral Nutrition Solutions Revenue by Type (2021-2026)
  4. 8.2.2 North America Parenteral Nutrition Solutions Revenue by Type (2027-2032)
  5. 8.3 North America Parenteral Nutrition Solutions Revenue Share by Type (2021-2032)
  6. 8.4 North America Parenteral Nutrition Solutions Revenue by Application (2021-2032)
  7. 8.4.1 North America Parenteral Nutrition Solutions Revenue by Application (2021-2026)
  8. 8.4.2 North America Parenteral Nutrition Solutions Revenue by Application (2027-2032)
  9. 8.5 North America Parenteral Nutrition Solutions Revenue Share by Application (2021-2032)
  10. 8.6 North America Parenteral Nutrition Solutions Revenue by Country
  11. 8.6.1 North America Parenteral Nutrition Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Parenteral Nutrition Solutions Revenue by Country (2021-2026)
  13. 8.6.3 North America Parenteral Nutrition Solutions Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Parenteral Nutrition Solutions Revenue (2021-2032)
  2. 9.2 Europe Parenteral Nutrition Solutions Revenue by Type (2021-2032)
  3. 9.2.1 Europe Parenteral Nutrition Solutions Revenue by Type (2021-2026)
  4. 9.2.2 Europe Parenteral Nutrition Solutions Revenue by Type (2027-2032)
  5. 9.3 Europe Parenteral Nutrition Solutions Revenue Share by Type (2021-2032)
  6. 9.4 Europe Parenteral Nutrition Solutions Revenue by Application (2021-2032)
  7. 9.4.1 Europe Parenteral Nutrition Solutions Revenue by Application (2021-2026)
  8. 9.4.2 Europe Parenteral Nutrition Solutions Revenue by Application (2027-2032)
  9. 9.5 Europe Parenteral Nutrition Solutions Revenue Share by Application (2021-2032)
  10. 9.6 Europe Parenteral Nutrition Solutions Revenue by Country
  11. 9.6.1 Europe Parenteral Nutrition Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Parenteral Nutrition Solutions Revenue by Country (2021-2026)
  13. 9.6.3 Europe Parenteral Nutrition Solutions Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Parenteral Nutrition Solutions Revenue (2021-2032)
  2. 10.2 China Parenteral Nutrition Solutions Revenue by Type (2021-2032)
  3. 10.2.1 China Parenteral Nutrition Solutions Revenue by Type (2021-2026)
  4. 10.2.2 China Parenteral Nutrition Solutions Revenue by Type (2027-2032)
  5. 10.3 China Parenteral Nutrition Solutions Revenue Share by Type (2021-2032)
  6. 10.4 China Parenteral Nutrition Solutions Revenue by Application (2021-2032)
  7. 10.4.1 China Parenteral Nutrition Solutions Revenue by Application (2021-2026)
  8. 10.4.2 China Parenteral Nutrition Solutions Revenue by Application (2027-2032)
  9. 10.5 China Parenteral Nutrition Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Parenteral Nutrition Solutions Revenue (2021-2032)
  2. 11.2 Asia Parenteral Nutrition Solutions Revenue by Type (2021-2032)
  3. 11.2.1 Asia Parenteral Nutrition Solutions Revenue by Type (2021-2026)
  4. 11.2.2 Asia Parenteral Nutrition Solutions Revenue by Type (2027-2032)
  5. 11.3 Asia Parenteral Nutrition Solutions Revenue Share by Type (2021-2032)
  6. 11.4 Asia Parenteral Nutrition Solutions Revenue by Application (2021-2032)
  7. 11.4.1 Asia Parenteral Nutrition Solutions Revenue by Application (2021-2026)
  8. 11.4.2 Asia Parenteral Nutrition Solutions Revenue by Application (2027-2032)
  9. 11.5 Asia Parenteral Nutrition Solutions Revenue Share by Application (2021-2032)
  10. 11.6 Asia Parenteral Nutrition Solutions Revenue by Country
  11. 11.6.1 Asia Parenteral Nutrition Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Parenteral Nutrition Solutions Revenue by Country (2021-2026)
  13. 11.6.3 Asia Parenteral Nutrition Solutions Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Parenteral Nutrition Solutions Revenue (2021-2032)
  2. 12.2 SAMEA Parenteral Nutrition Solutions Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Parenteral Nutrition Solutions Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Parenteral Nutrition Solutions Revenue by Type (2027-2032)
  5. 12.3 SAMEA Parenteral Nutrition Solutions Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Parenteral Nutrition Solutions Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Parenteral Nutrition Solutions Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Parenteral Nutrition Solutions Revenue by Application (2027-2032)
  9. 12.5 SAMEA Parenteral Nutrition Solutions Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Parenteral Nutrition Solutions Revenue by Country
  11. 12.6.1 SAMEA Parenteral Nutrition Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Parenteral Nutrition Solutions Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Parenteral Nutrition Solutions Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst